Indeed, the SCC marker DNp63 was significantly downregulated, and the adenocarcinoma markers TTF1 and napsin A were markedly upregulated (Figure 1B), suggesting that silencing of S100A7 attenuated lung ADC to SCC transdifferentiation. The gene discussed is NAPSA; the disease is medical procedure.